Pure Biologics Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.11	0.31	3.61	2.26	6.18	8.96
Short-Term Investments	-	-	-	4.92	26.75	-
Cash & Short-Term Investments	0.11	0.31	3.61	7.18	32.93	8.96
Cash Growth	-91.26%	-91.32%	-49.76%	-78.20%	267.68%	-35.67%
Accounts Receivable	0.04	0.23	0.02	0.15	0.05	0.02
Other Receivables	0.82	1.45	14.73	15.07	9.24	1.34
Receivables	0.86	1.67	14.75	15.22	9.29	1.35
Prepaid Expenses	-	0.02	0.03	0.02	0.03	0.02
Other Current Assets	0.34	0.1	3.22	1.76	0.77	2.71
Total Current Assets	1.32	2.11	21.6	24.17	43.02	13.04
Property, Plant & Equipment	-	0.13	3.7	8.42	3.45	4.88
Long-Term Investments	-	-	-	0.02	0.02	-
Other Intangible Assets	0.01	0.12	0.26	0.29	0.33	0.37
Long-Term Deferred Charges	-	-	-	0.11	0.39	0.65
Other Long-Term Assets	-	-0.01	-2.82	-	-	-
Total Assets	1.33	2.34	22.74	33.01	47.19	18.94
Accounts Payable	2.57	0.85	1.03	7.24	0.67	2.76
Accrued Expenses	0.43	0.41	0.92	1.64	0.08	1.49
Current Portion of Long-Term Debt	14.97	13.96	-	-	-	-
Current Portion of Leases	-	0.1	0.09	1.1	1.11	1.38
Current Unearned Revenue	-	-	4.81	2.79	3.68	12.23
Other Current Liabilities	2.75	0.14	1.15	0.08	0	0.15
Total Current Liabilities	20.72	15.46	7.99	12.83	5.55	18
Long-Term Debt	-	-	12.72	-	-	-
Long-Term Leases	-	-	0.13	1.77	2	3.63
Long-Term Unearned Revenue	-	-	-	0.07	0.11	0.15
Pension & Post-Retirement Benefits	-	-	-	0.04	0.04	0.05
Other Long-Term Liabilities	-	-	-	-	0	0
Total Liabilities	20.72	15.46	20.85	14.71	7.7	21.83
Common Stock	0.41	0.38	0.33	0.23	0.23	0.17
Additional Paid-In Capital	99.84	98.85	90.57	75.31	70.89	16.82
Retained Earnings	-119.64	-112.36	-92.93	-57.24	-31.63	-19.87
Comprehensive Income & Other	0	0.02	3.92	0	-	0
Shareholders' Equity	-19.39	-13.12	1.89	18.3	39.49	-2.89
Total Liabilities & Equity	1.33	2.34	22.74	33.01	47.19	18.94
Total Debt	14.97	14.06	12.94	2.86	3.11	5.01
Net Cash (Debt)	-14.86	-13.75	-9.33	4.32	29.82	3.95
Net Cash Growth	-	-	-	-85.52%	654.64%	-53.78%
Net Cash Per Share	-3.75	-3.94	-2.93	1.92	13.42	2.39
Filing Date Shares Outstanding	8.16	3.75	3.33	2.25	2.25	1.65
Total Common Shares Outstanding	4.08	3.75	3.33	2.25	2.25	2.25
Working Capital	-19.4	-13.35	13.61	11.34	37.47	-4.96
Book Value Per Share	-4.75	-3.50	0.57	8.12	17.52	-1.28
Tangible Book Value	-19.4	-13.23	1.64	18.01	39.16	-3.26
Tangible Book Value Per Share	-4.75	-3.53	0.49	7.99	17.37	-1.45
Land	-	-	-	0.1	0.87	-
Machinery	-	0.54	11.25	11.95	10.95	9.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.